tirzepatide lawsuit 2025 Lilly asks to join over compounded versions of its weight-loss drugs ADA 2025: Advances in Type

Body aches appear in post-marketing reports, but at rates that do not suggest a strong pharmacological link

Injection site reactions and allergic reactions are more common in people whose immune systems make anti-drug antibodies (ADAs) in response to tirzepatide

The impact of tirzepatide and semaglutide on the cardiovascular risk reduction on the population level in the USA is projected as the preventable CVD events over 10 years if the eligible population without CVD history is treated with tirzepatide or semaglutide, respectively, calculated for each treatment by multiplying 10-year CV risk reduction derived for tirzepatide and semaglutide respectively with the treatment-eligible populations without prior CVD events

Handling and Storage Recommendations Minimize light exposure

Effects of Rs6234/Rs6235 and Rs6232/Rs6234/Rs6235 PCSK1 Single-Nucleotide Polymorphism Clusters on Proprotein Convertase 1/3 Biosynthesis and Activity. Molecular Genetics and Metabolism, vol